Zileuton, a 5-lipoxygenase inhibitor, is a primary intervention for the prophylaxis and treatment of chronic asthma in patients aged 12 and older. Although zileuton is frequently administered in conjunction with inhaled corticosteroids for chronic asthma, it is not effective for managing acute asthma attacks.
Copyright © 2024, StatPearls Publishing LLC.